RP
Rapid Micro Biosystems, Inc.
RPID · NASDAQ
$0.86 -4.01% (-$0.04)
1M -28.79%
Market Cap $39.1M
P/E Ratio -
Div. Yield -
ROE 177.04%
Bulios Fair Price
$1.19
38.1% upside
Current Price
$0.86
Undervalued Fair Value Overvalued
According to Bulios Fair Price, RPID is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
2/9Valuation
91 /100
Cheap P/B 2.20x
P/S 1.11x
EV/FFO N/A
Growth
78 /100
Growing Book val. growth 41.30%
Rev. growth 25.15%
FCF growth N/A
Profitability
1 /100
Weak Net margin 145.56%
Op. margin 141.45%
FCF margin 114.83%
Quality
8 /100
Poor ROE 177.04%
ROA 87.60%
Asset turnover 0.60x
Debt
42 /100
Moderate Current ratio 2.55x
Int. coverage -19.36x
Debt/Equity 1.32x
Stability
71 /100
Stable Rev. volatility 5.88%
EPS volatility 6.16%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about RPID
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Robert G. Spignesi Jr.
Employees
171
Headquarters
Lexington
Upcoming events
06 NOV
Earnings
Upcoming earnings report